Home > Press > Nearly 40 Early- to Late-Stage Med Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innova
February 27-29, 2008, The Venetian, Las Vegas
Nearly 40 Early- to Late-Stage Med Device Companies Confirmed to Date to Present at Medtech Insight and Windhover Informationís ''Investment In Innova
NEWPORT BEACH, CA | Posted on December 20th, 2007
Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that almost 40 promising early- to late-stage medical device companies seeking funding and/or strategic partnership are now confirmed to present at its "Investment In Innovation (In3) West" conference, being held February 27-29, 2008 at The Venetian Resort-Hotel-Casino in Las Vegas, Nevada. The two-day In3 West event (www.windhover.com/in3west08) - the company's 29th In3 conference - will showcase a total of over 50 innovative young medtech companies from around the world presenting (many for the first time on our stage) to an audience of 250+ senior business development and investment executives from the leading medical technology and healthcare investment firms, for purposes of raising funding or forming strategic partnerships.
Presentations from this group of cutting-edge early- to late-stage companies, carefully selected by our staff and Advisory Board of expert healthcare investment professionals, will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few. Presenters confirmed to date include Angel Medical Systems, Armune BioScience, BioTelligent, Cardiac Output Technologies, Cohera Medical, CoreSpine Technologies, Crospon, Deca-Medics, eCardio Diagnostics, HealthLink Europe, HemoBioTech, Hepgen, Infrared Sciences, Innovent Medical Solutions, Light Sciences Oncology, Minnow Medical, Moerae Matrix, Nerites, Nesos Health, Photo Dynamic Therapy, PolyRemedy, Portland Orthopaedic, Praxim, Provista Life Sciences, Seno Medical Instruments, Sunshine Heart Company, TheraCardia, ThermopeutiX, Tissue Genetics, Ultimate Spine, ValveXchange, VeinAid, Victhom Human Bionics, Vivoxid, Xylos Corporation, and Zassi Medical Evolutions, among many others being added to the program regularly.
The In3 West format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature a presenting company product exhibition/networking reception, plenary sessions by device industry thought leaders, a Manufacturer Perspective panel discussion/case study titled "What Are Buyers Looking for in 2008?", a Venture Perspective panel discussion/case study, "Doing Innovative or Unconventional Deals," educational workshops for start-up companies, and much more.
Event co-sponsors include AdvaMed, Battelle, Business Wire, Curran International, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, and Ronald Trahan Associates.
Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1300 emerging medical technology company presenters and over 7000 attendees have participated at In3 events over the past 7 years.
To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail . Attendees can register on the Medtech Insight website at www.windhover.com/in3west08; the discounted $1295 attendee registration rate ($200 off) expires December 31, 2007.
Visit http://www.medtechinsight.com/pastpresenters.html for a full list of previous Medtech Insight conference presenters and their technology descriptions. To read what past attendees and industry experts think of Medtech Insight's investment and partnering events, please visit http://www.medtechinsight.com/in3success.html .
The company's Spring 2008 In3 event -- In3 Europe -- will be held in Paris, France, April 28-30. Information on this exciting international medtech investment conference will be posted soon on the Medtech Insight website.
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.
For more information, please click here
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014
Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014
RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014
Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014
Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014
QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014
Advancing thin film research with nanostructured AZO: Innovnanoís unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014
Iran-Made Respiratory Nano Masks Provided to Hajj Pilgrims October 23rd, 2014
MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014
SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014
NanoTechnology for Defense (NT4D) October 22nd, 2014